OICR Invests in Personalized Medicine Spin-offs | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research said today that it has made equity investments in two new University of Toronto spin-off projects that are focused on developing molecular diagnostic technologies for use in cancer screening and treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.